Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3
Clinical trial NCT01808248 · COMPLETED
Trial details
- NCT number
- NCT01808248
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2013-09-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.